John Pratt - Net Worth and Insider Trading

John Pratt Net Worth

The estimated net worth of John Pratt is at least $0 dollars as of 2024-04-25. John Pratt is the General Manager, San Diego of Pacira BioSciences Inc and owns about 0 shares of Pacira BioSciences Inc (PCRX) stock worth over $0. Details can be seen in John Pratt's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John Pratt has not made any transactions after 2013-06-13 and currently still holds the listed stock(s).

Transaction Summary of John Pratt

To

John Pratt Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John Pratt owns 1 companies in total, including Pacira BioSciences Inc (PCRX) .

Click here to see the complete history of John Pratt’s form 4 insider trades.

Insider Ownership Summary of John Pratt

Ticker Comapny Transaction Date Type of Owner
PCRX Pacira BioSciences Inc 2013-06-13 General Manager & San Diego

John Pratt Latest Holdings Summary

John Pratt currently owns a total of 1 stock. John Pratt owns 0 shares of Pacira BioSciences Inc (PCRX) as of June 13, 2013, with a value of $0.

Latest Holdings of John Pratt

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PCRX Pacira BioSciences Inc 2013-06-13 0 25.50 0

Holding Weightings of John Pratt


John Pratt Form 4 Trading Tracker

According to the SEC Form 4 filings, John Pratt has made a total of 0 transactions in Pacira BioSciences Inc (PCRX) over the past 5 years. The most-recent trade in Pacira BioSciences Inc is the sale of 21,032 shares on June 13, 2013, which brought John Pratt around $630,960.

Insider Trading History of John Pratt

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John Pratt Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

John Pratt Ownership Network

Ownership Network List of John Pratt

No Data

Ownership Network Relation of John Pratt


John Pratt Owned Company Details

What does Pacira BioSciences Inc do?

Who are the key executives at Pacira BioSciences Inc?

John Pratt is the General Manager & San Diego of Pacira BioSciences Inc. Other key executives at Pacira BioSciences Inc include Chief Clinical Officer Roy Winston , Executive Director & Accounting Lauren Bullaro Riker , and CAO and General Counsel Kristen Marie Williams .

Pacira BioSciences Inc (PCRX) Insider Trades Summary

Over the past 18 months, John Pratt made no insider transaction in Pacira BioSciences Inc (PCRX). Other recent insider transactions involving Pacira BioSciences Inc (PCRX) include a net sale of 8,216 shares made by Lauren Bullaro Riker , a net sale of 124,338 shares made by Gary W Pace , and a net sale of 9,125 shares made by Kristen Marie Williams .

In summary, during the past 3 months, insiders sold 119,323 shares of Pacira BioSciences Inc (PCRX) in total and bought 0 shares, with a net sale of 119,323 shares. During the past 18 months, 209,500 shares of Pacira BioSciences Inc (PCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 209,500 shares.

Pacira BioSciences Inc (PCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Pacira BioSciences Inc Insider Transactions

No Available Data

John Pratt Mailing Address

Above is the net worth, insider trading, and ownership report for John Pratt. You might contact John Pratt via mailing address: 10450 Science Center Drive, San Diego Ca 92121.

Discussions on John Pratt

No discussions yet.